Financial Times
Clustered Story
Trump administration reverses move to block Moderna flu vaccine trial
Financial Times · Feb 18, 2026 · Collected from RSS
Summary
U-turn comes after backlash from the company and US biotech industry
Full Article
Subscribe to unlock this articleSave over 40% on Standard Digitalwas $540 now $299 for your first yearSave now on essential digital access to trusted FT journalism on any device. Savings based on monthly annualised price - offer ends 25th FebruaryExplore more offers.Trial$1 for 4 weeksThen $75 per month. Complete digital access to quality FT journalism on any device. Cancel or change your plan anytime during your trial.Premium DigitalComplete coverage$75 per monthComplete digital access with exclusive insights and industry deep dives on any device.PrintSave 60% + FREE Deliverywas $409 now $149 for your first yearDelivery Monday - Saturday, including FT Weekend and FT Digital Edition: all the content of the FT newspaper on any device. Savings based on annual price.Explore our full range of subscriptions.Discover all the plans currently available in your countryDigital access for organisations. Includes exclusive features and content.Why the FT?See why over a million readers pay to read the Financial Times.Find out why
Share this story